HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by von Eckardstein, A. Articles by Assmann, G. Search for Related Content PubMed PubMed Citation Articles by von Eckardstein, A. Articles by Assmann, G. Social Bookmarking                      What's this?

The Journal of Lipid Research, Vol. 39, 987-998, May 1998
Copyright © 1998 by Lipid Research, Inc.

Original Article

Plasma and fibroblasts of Tangier disease patients are disturbed in transferring phospholipids onto apolipoprotein A-I

Correspondence to: Arnold von Eckardstein.

Plasmas of patients with Tangier disease (TD) lack lipid-rich -HDL which, in normal plasma, constitutes the majority of high density lipoprotein (HDL). Residual amounts of apolipoprotein (apo)A-I in TD plasma occur as lipid-poor or even lipid-free preß-HDL. By contrast to normal plasma, TD plasma does not convert preß-HDL into -HDL. Moreover, fibroblasts of TD patients were found to be defective in secreting cholesterol or phospholipids in the presence of lipid-free apoA-I. We have therefore hypothesized that both defective conversion of preß-HDL into -HDL and defective lipid efflux from TD cells onto lipid-free apoA-I result from a disturbance in phospholipid transfer occurring in both cellular and extracellular compartments. To test this hypothesis we established an assay that measures the activity of plasma, cells, and cell culture media to transfer radiolabeled phosphatidylcholine (PC), phosphatidylethanolamine (PE), and phosphatidylinositol (PI) from vesicles onto apoA-I, apoA-II, albumin, or reconstituted HDL. Plasmas, HDL, and lipoprotein-depleted plasma of normolipidemic probands as well as cell homogenates and culture media of normal fibroblasts were active at 37°C but not at 4°C in transferring radiolabeled PC, PI, and PE dose- and time-dependently onto either lipid-free apoA-I or reconstituted HDL. Transfer of glycerophospholipids onto apoA-II was much lower than onto apoA-I; transfer onto albumin was close to background. Compared to ten normolipidemic plasmas and four apoA-I-deficient plasmas, plasmas of six TD patients were significantly reduced by 40–50% in their glycerophospholipid transfer activities. Compared to eight normal fibroblast cell lines, homogenates and culture media of four TD fibroblast cell lines were reduced by 40–50% and 30–35%, respectively, in their activity to transfer PC, PI, or PE onto apoA-I.

Our data suggest that in TD the same mechanism underlies both defective conversion of preß-HDL into -HDL and impaired efflux of cellular lipids, namely a defective phospholipid transfer.—von Eckardstein, A., A. Chirazi, S. Schuler-Lüttmann, M. Walter, J. J. P. Kastelein, J. Geisel, J. T. Real, R. Miccoli, G. Noseda, G. Höbbel, and G. Assmann. Plasma and fibroblasts of Tangier disease patients are disturbed in transferring phospholipids onto apolipoprotein A-I. J. Lipid Res. 1998. 39: 987–998.

Supplementary key words: prebeta-HDL, familial HDL deficiency, reverse cholesterol transport, cholesterol efflux, phospholipid transfer proteins

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				R. R. Singaraja, M. Van Eck, N. Bissada, F. Zimetti, H. L. Collins, R. B. Hildebrand, A. Hayden, L. R. Brunham, M. H. Kang, J.-C. Fruchart, et al. Both Hepatic and Extrahepatic ABCA1 Have Discrete and Essential Functions in the Maintenance of Plasma High-Density Lipoprotein Cholesterol Levels In Vivo Circulation, September 19, 2006; 114(12): 1301 - 1309. [Abstract] [Full Text] [PDF]

				N. Alder-Baerens, P. Muller, A. Pohl, T. Korte, Y. Hamon, G. Chimini, T. Pomorski, and A. Herrmann Headgroup-specific Exposure of Phospholipids in ABCA1-expressing Cells J. Biol. Chem., July 15, 2005; 280(28): 26321 - 26329. [Abstract] [Full Text] [PDF]

				G Kolovou, D Daskalova, K Anagnostopoulou, I Hoursalas, V Voudris, D P Mikhailidis, and D V Cokkinos Postprandial hypertriglyceridaemia in patients with Tangier disease J. Clin. Pathol., December 1, 2003; 56(12): 937 - 941. [Abstract] [Full Text] [PDF]

				A. D. Attie, Y. Hamon, A. R. Brooks-Wilson, M. P. Gray-Keller, M. L. E. MacDonald, V. Rigot, A. Tebon, L.-H. Zhang, J. D. Mulligan, R. R. Singaraja, et al. Identification and functional analysis of a naturally occurring E89K mutation in the ABCA1 gene of the WHAM chicken J. Lipid Res., October 1, 2002; 43(10): 1610 - 1617. [Abstract] [Full Text] [PDF]

				T. Oka, S. Yamashita, T. Kujiraoka, M. Ito, M. Nagano, Y. Sagehashi, T. Egashira, M. N. Nanjee, K.-i. Hirano, N. E. Miller, et al. Distribution of human plasma PLTP mass and activity in hypo- and hyperalphalipoproteinemia J. Lipid Res., August 1, 2002; 43(8): 1236 - 1243. [Abstract] [Full Text] [PDF]

				R. Arakawa, S. Abe-Dohmae, M. Asai, J.-i. Ito, and S. Yokoyama Involvement of caveolin-1 in cholesterol enrichment of high density lipoprotein during its assembly by apolipoprotein and THP-1 cells J. Lipid Res., December 1, 2000; 41(12): 1952 - 1962. [Abstract] [Full Text]

				D. Sviridov, L. E. Pyle, M. Jauhiainen, C. Ehnholm, and N. H. Fidge Deletion of the propeptide of apolipoprotein A-I reduces protein expression but stimulates effective conversion of pre{beta}-high density lipoprotein to {alpha}-high density lipoprotein J. Lipid Res., November 1, 2000; 41(11): 1872 - 1882. [Abstract] [Full Text]

				M. N. Nanjee and E. A. Brinton Very Small Apolipoprotein A-I-containing Particles from Human Plasma: Isolation and Quantification by High-Performance Size-Exclusion Chromatography Clin. Chem., February 1, 2000; 46(2): 207 - 223. [Abstract] [Full Text] [PDF]

				J. Raper, R. Fung, J. Ghiso, V. Nussenzweig, and S. Tomlinson Characterization of a Novel Trypanosome Lytic Factor from Human Serum Infect. Immun., April 1, 1999; 67(4): 1910 - 1916. [Abstract] [Full Text] [PDF]

				A. E. Bortnick, G. H. Rothblat, G. Stoudt, K. L. Hoppe, L. J. Royer, J. McNeish, and O. L. Francone The Correlation of ATP-binding Cassette 1 mRNA Levels with Cholesterol Efflux from Various Cell Lines J. Biol. Chem., September 8, 2000; 275(37): 28634 - 28640. [Abstract] [Full Text] [PDF]

				L. B. Cavelier, Y. Qiu, J. K. Bielicki, V. Afzal, J.-F. Cheng, and E. M. Rubin Regulation and Activity of the Human ABCA1 Gene in Transgenic Mice J. Biol. Chem., May 18, 2001; 276(21): 18046 - 18051. [Abstract] [Full Text] [PDF]